Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niels Hansen

Showing results (181-190 of 205) with videos related to

Pageof 21
Sort By:
Journal of Neurology|September 10, 2024
GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA)Sabrina Katzdobler, Georg Nübling, Martin Klietz, et al.
Frontiers in Aging Neuroscience|May 10, 2021
Hippocampal and Hippocampal-Subfield Volumes From Early-Onset Major Depression and Bipolar Disorder to Cognitive DeclineNiels Hansen, Aditya Singh, Claudia Bartels, et al.
Journal of Neurology|December 24, 2025
CSF biomarkers of neuroinflammation are associated with regional atrophySerap Özlü, Martin Dyrba, Alice Grazia, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 23, 2026
Alpha-synuclein quantitative seed amplification assay predicts conversion to dementiaStefan Bräuer, Verena Sondermann, Iñaki Schniewind, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Subjective cognition trajectories, Alzheimer biomarkers, and incident mild cognitive impairmentElizabeth Kuhn, Luca Kleinedam, Melina Stark, et al.
The Journal of Prevention of Alzheimer'S Disease|May 29, 2026
Subjective cognition trajectories, Alzheimer biomarkers, and incident mild cognitive impairmentElizabeth Kuhn, Luca Kleineidam, Melina Stark, et al.
Neurology|September 20, 2024
Association of Neurogranin and BACE1 With Clinical Cognitive Decline in Individuals With Subjective Cognitive DeclineXiao Wang, Silka D Freiesleben, Luisa-Sophie Schneider, et al.
Journal of Alzheimer'S Disease Reports|October 18, 2023
Cognitive Trajectories in Preclinical and Prodromal Alzheimer's Disease Related to Amyloid Status and Brain Atrophy: A Bayesian ApproachStefan J Teipel, Martin Dyrba, Fedor Levin, et al.
Communications Medicine|December 10, 2024
Blood-based quantification of Aβ oligomers indicates impaired clearance from brain in ApoE ε4 positive subjectsLara Blömeke, Fabian Rehn, Marlene Pils, et al.
Scientific Reports|March 14, 2024
Whole-body metabolic modelling reveals microbiome and genomic interactions on reduced urine formate levels in Alzheimer's diseaseFilippo Martinelli, Almut Heinken, Ann-Kristin Henning, et al.
Pageof 21

Showing results (181-190 of 205) with videos related to

Sort By:
Pageof 21
Journal of Neurology|September 10, 2024
GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA)Sabrina Katzdobler, Georg Nübling, Martin Klietz, et al.
Frontiers in Aging Neuroscience|May 10, 2021
Hippocampal and Hippocampal-Subfield Volumes From Early-Onset Major Depression and Bipolar Disorder to Cognitive DeclineNiels Hansen, Aditya Singh, Claudia Bartels, et al.
Journal of Neurology|December 24, 2025
CSF biomarkers of neuroinflammation are associated with regional atrophySerap Özlü, Martin Dyrba, Alice Grazia, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 23, 2026
Alpha-synuclein quantitative seed amplification assay predicts conversion to dementiaStefan Bräuer, Verena Sondermann, Iñaki Schniewind, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Subjective cognition trajectories, Alzheimer biomarkers, and incident mild cognitive impairmentElizabeth Kuhn, Luca Kleinedam, Melina Stark, et al.
The Journal of Prevention of Alzheimer'S Disease|May 29, 2026
Subjective cognition trajectories, Alzheimer biomarkers, and incident mild cognitive impairmentElizabeth Kuhn, Luca Kleineidam, Melina Stark, et al.
Neurology|September 20, 2024
Association of Neurogranin and BACE1 With Clinical Cognitive Decline in Individuals With Subjective Cognitive DeclineXiao Wang, Silka D Freiesleben, Luisa-Sophie Schneider, et al.
Journal of Alzheimer'S Disease Reports|October 18, 2023
Cognitive Trajectories in Preclinical and Prodromal Alzheimer's Disease Related to Amyloid Status and Brain Atrophy: A Bayesian ApproachStefan J Teipel, Martin Dyrba, Fedor Levin, et al.
Communications Medicine|December 10, 2024
Blood-based quantification of Aβ oligomers indicates impaired clearance from brain in ApoE ε4 positive subjectsLara Blömeke, Fabian Rehn, Marlene Pils, et al.
Scientific Reports|March 14, 2024
Whole-body metabolic modelling reveals microbiome and genomic interactions on reduced urine formate levels in Alzheimer's diseaseFilippo Martinelli, Almut Heinken, Ann-Kristin Henning, et al.
Pageof 21